Related Experiment Video
Updated: May 5, 2026
10:13
Cannula Implantation into the Cisterna Magna of Rodents
Published on: May 23, 2018
46.2K
The glymphatic system in Huntington's disease
Wenzhen Duan1,2, Yuan Zhou1, Hongshuai Liu1
1Division of Neurobiology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Journal of Huntington'S Disease
|March 28, 2025
Summary
The brain's glymphatic system clears waste and supports homeostasis. This review explores its dysfunction in Huntington's disease (HD) and potential therapeutic strategies.
Area of Science:
- Neuroscience
- Cell Biology
- Physiology
Background:
- The glymphatic system, a brain waste clearance network, is crucial for neuronal health and homeostasis.
- It facilitates cerebrospinal fluid (CSF) and interstitial fluid (ISF) exchange, mediated by aquaporin 4 (AQP4) channels on astrocytes.
- Glymphatic dysfunction is increasingly linked to neurodegenerative diseases.
Purpose of the Study:
- To examine the role of glymphatic system dysfunction in Huntington's disease (HD) pathogenesis.
- To highlight potential therapeutic avenues for optimizing glymphatic function in HD management.
- To review current research and suggest future directions for glymphatic system research in HD.
Main Methods:
- Literature review of studies on glymphatic system function and dysfunction.
- Analysis of evidence linking glymphatic impairment to neurodegenerative disorders, specifically HD.
- Exploration of pharmacological and lifestyle interventions targeting glymphatic pathways.
Main Results:
- Glymphatic system dysfunction is implicated in the progression of Huntington's disease.
- Proper glymphatic function depends on aquaporin 4 (AQP4) water channel distribution and astrocytic polarization.
- Dysfunction in this clearance pathway may contribute to the accumulation of toxic proteins in HD.
Conclusions:
- Understanding glymphatic system involvement in HD pathogenesis offers novel therapeutic targets.
- Optimizing glymphatic function through interventions may improve HD management and patient outcomes.
- Further research is needed to fully elucidate the glymphatic system's role in HD and develop effective treatments.
Related Concept Videos
01:22Lysosomal Hydrolases
3.5K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
01:22Cerebral Edema ll: Pathophysiology
19
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
19
01:23Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
01:24Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
01:21Huntington Disease l: Introduction
110
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
110